Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Core Points - Serina Therapeutics, Inc. has scheduled its 2025 annual meeting of stockholders for November 7, 2025 [1] - The deadline for stockholder proposals under Rule 14a-8 is set for August 15, 2025, due to the change in the meeting date [2] - Stockholder proposals and director nominations must be submitted in writing between July 10, 2025, and August 9, 2025, to be considered timely [3] Company Overview - Serina is a clinical-stage biotechnology company focused on developing drug candidates for neurological diseases and other indications [4] - The company utilizes its POZ Platform to enhance the efficacy and safety profiles of various therapeutic modalities, including small molecules and RNA-based therapeutics [4] - Serina is headquartered in Huntsville, Alabama, at the HudsonAlpha Institute of Biotechnology [4]